NEW YORK ( TheStreet) -- Amedisys (Nasdaq: AMED) is trading at unusually high volume Wednesday with 2.2 million shares changing hands. It is currently at four times its average daily volume and trading down $2.78 (-20.7%) at $10.64 as of 2:10 p.m. ET. Amedisys has a market cap of $451.5 million and is part of the health care sector and health services industry. Shares are up 23% year to date as of the close of trading on Tuesday. Amedisys, Inc., a health care company, provides home health and hospice services primarily in the United States. It operates in two segments, Home Health and Hospice. TheStreet Ratings rates Amedisys as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full Amedisys Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.